Theresa Wingrove
Conseiller Juridique Général chez IMMUNOGEN, INC.
Profil
Theresa G.
Wingrove is currently the Senior Vice President-Regulatory Affairs & Quality at ImmunoGen, Inc. She previously worked as the Senior Director-Clinical & Regulatory Affairs at MediSpectra, Inc. from 2000 to 2010.
She also held the position of Vice President-Clinical & Regulatory Affairs at Histogenics Corp.
from 2006 to 2011.
Dr. Wingrove has a doctorate degree from Rochester Christian University and an undergraduate degree from Brown University.
Postes actifs de Theresa Wingrove
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOGEN, INC. | Conseiller Juridique Général | 01/01/2011 |
Anciens postes connus de Theresa Wingrove
| Sociétés | Poste | Fin |
|---|---|---|
| OCUGEN, INC. | Directeur Technique/Scientifique/R&D | 01/01/2011 |
MediSpectra, Inc.
 MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services MediSpectra, Inc. develops and manufactures medical devices. The firm develops proprietary optical detection technology for enhanced accuracy and real time results in the detection of cancer & other human tissue abnormalities. Its technology is based on multimodal optical interrogation of tissues with light. The company was founded in 1995 and is headquartered in Lexington, MA. | Directeur Technique/Scientifique/R&D | 26/03/2010 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Formation de Theresa Wingrove
| Brown University | Undergraduate Degree |
| Rochester Christian University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
MediSpectra, Inc.
MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services MediSpectra, Inc. develops and manufactures medical devices. The firm develops proprietary optical detection technology for enhanced accuracy and real time results in the detection of cancer & other human tissue abnormalities. Its technology is based on multimodal optical interrogation of tissues with light. The company was founded in 1995 and is headquartered in Lexington, MA. | Commercial Services |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
